Abstract
Objectives: Endometrial preparation provides significant surgical benefits prior to hysteroscopic procedures. However, there is still no consensus on the optimal presurgical protocol. Although there is evidence on rapid preparation, there are currently no studies on rapid endometrial preparation using combined oral contraceptives initiated at a “random” time in the menstrual cycle. The aim of the present trial was to evaluate the use of oral drospirenone/estetrol in random start rapid preparation of endometrium before office hysteroscopic polypectomy. Design: In this multicenter, prospective, randomized controlled trial, 80 women scheduled for polypectomy were randomly assigned to intervention (n = 40) or control (n = 40) groups. Participants/Materials, Setting, Methods: The intervention group received oral drospirenone/estetrol (3 mg/14.2 mg/day) for 14 days, starting at any menstrual cycle point (random start). Controls underwent polypectomy on cycle days 8–11 without any prior pharmacological intervention. Results: Pre- and post-procedure, endometrial thickness was significantly lower in the drospirenone/estetrol group (p < 0.001), and patients showed more hypotrophic/atrophic endometrial patterns (p < 0.001). Operative time, distension medium usage, incomplete resections, and bleeding during polypectomy were significantly lower in the drospirenone/estetrol group (p < 0.001). Endometrial preparation quality, uterine cavity visualization, and procedure satisfaction were higher in the drospirenone/estetrol group (p < 0.001). Furthermore, patients in the drospirenone/estetrol group experienced less pain during (p < 0.001) and after the procedure (p < 0.001), requiring fewer analgesics (p < 0.001) and shorter post-procedure discharge time (p = 0.01) than controls. Limitations: Limited sample size; possible variability due to different hysteroscopists, caused by the multicenter nature of the study; hysteroscopists were unmasked to treatment allocation; absence of a cost-effectiveness analysis. Conclusions: Treatment with drospirenone/estetrol could provide rapid, satisfactory and low-cost endometrial preparation before office polypectomy, improving surgical performance and patient compliance.
Journal Section:
Research Article
References
1.
Mazzon
I
, Etrusco
A
, Laganà
AS
, Chiantera
V
, Di Angelo Antonio
S
, Tosto
V
, et al. Training in diagnostic hysteroscopy: the “arbor vitae” method
. Med Kaunas
. 2023
;59
(6
):1019
. 2.
Vitale
SG
, Haimovich
S
, Laganà
AS
, Alonso
L
, Di Spiezio Sardo
A
, Carugno
J
, et al. Endometrial polyps. An evidence-based diagnosis and management guide
. Eur J Obstet Gynecol Reprod Biol
. 2021
;260
:70
–7
. 3.
Etrusco
A
, Laganà
AS
, Chiantera
V
, Vitagliano
A
, Cicinelli
E
, Mikuš
M
, et al. Feasibility and surgical outcomes of hysteroscopic myomectomy of FIGO type 3 myoma: a systematic review
. J Clin Med
. 2023
;12
(15
):4953
. 4.
Jegaden
M
, Bleas
C
, Debras
E
, Couet
D
, Pourcelot
A-G
, Capmas
P
, et al. Asherman syndrome after uterine artery embolization: a cohort study about surgery management and fertility outcomes
. J Minim Invasive Gynecol
. 2023
;30
(6
):494
–501
. 5.
Urman
B
, Yakin
K
, Ertas
S
, Alper
E
, Aksakal
E
, Riemma
G
, et al. Fertility and anatomical outcomes following hysteroscopic adhesiolysis: an 11-year retrospective cohort study to validate a new classification system for intrauterine adhesions (Urman-Vitale Classification System)
. Int J Gynaecol Obstet
. 2024
;165
(2
):644
–54
. 6.
Gambadauro
P
, Martínez-Maestre
MA
, Torrejón
R
. When is see-and-treat hysteroscopic polypectomy successful
. Eur J Obstet Gynecol Reprod Biol
. 2014
;178
:70
–3
. 7.
Rai
VS
, Gillmer
MDG
, Gray
W
. Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium
. Hum Reprod
. 2000
;15
(9
):1989
–92
. 8.
Corrêa
TD
, Caetano
IM
, Saraiva
PHT
, Noviello
MB
, Santos Filho
AS
. Use of GnRH analogues in the reduction of submucous fibroid for surgical hysteroscopy: a systematic review and meta-analysis
. Rev Bras Ginecol Obstet
. 2020
;42
(10
):649
–58
. 9.
Haimovich
S
, Mancebo
G
, Alameda
F
, Agramunt
S
, Hernández
JL
, Carreras
R
. Endometrial preparation with desogestrel before Essure hysteroscopic sterilization: preliminary study
. J Minim Invasive Gynecol
. 2013
;20
(5
):591
–4
. 10.
Cicinelli
E
, Pinto
V
, Tinelli
R
, Saliani
N
, De Leo
V
, Cianci
A
. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study
. Fertil Steril
. 2007
;88
(3
):698
–701
. 11.
Florio
P
, Imperatore
A
, Litta
P
, Franchini
M
, Calzolari
S
, Angioni
S
, et al. The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women
. Steroids
. 2010
;75
(12
):912
–7
. 12.
Schulz
KF
, Altman
DG
, Moher
D
; CONSORT Group
. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
. BMJ
. 2010
;340
:c332
. 13.
Chan
A-W
, Tetzlaff
JM
, Gøtzsche
PC
, Altman
DG
, Mann
H
, Berlin
JA
, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
. BMJ
. 2013
;346
:e7586
. 14.
Baggish
MS
, Valle
RF
, Barbot
J
. Diagnostic and operative hysteroscopy: a text and atlas
. Year Book Medical Publishers
; 1989
.15.
Obstet Gynecol
. The use of hysteroscopy for the diagnosis and treatment of intrauterine pathology: ACOG committee opinion, number 800
. Obstet Gynecol
. 2020
;135
(3
):e138
–48
. 16.
Tan
YH
, Lethaby
A
. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
. Cochrane Database Syst Rev
. 2013
;2013
(11
):CD010241
. 17.
Laganà
AS
, Giacobbe
V
, Triolo
O
, Granese
R
, Ban Frangež
H
, Vrtačnik-Bokal
E
, et al. Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study
. Gynecol Endocrinol
. 2016
;32
(5
):408
–11
. 18.
Kamath
MS
, Kalampokas
EE
, Kalampokas
TE
. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis
. Eur J Obstet Gynecol Reprod Biol
. 2014
;177
:11
–8
. 19.
Etrusco
A
, Agrifoglio
V
, Chiantera
V
, D’Amato
A
, Russo
G
, Golia D’Augè
T
, et al. The use of oral nomegestrol acetate/estradiol in rapid and random start preparation of endometrium before office hysteroscopic polypectomies: a multicenter, prospective, randomized controlled trial
. Eur J Obstet Gynecol Reprod Biol
. 2024
;299
:213
–8
. 20.
Etrusco
A
, D’Amato
A
, Agrifoglio
V
, Chiantera
V
, Russo
G
, D’Augè
TG
, et al. Rapid and random-start endometrial preparation before outpatient hysteroscopic polypectomy in patients of perimenopausal age
. Climacteric
. 2024
;27
(6
):561
–7
. 21.
Paton
DM
. Estetrol and drospirenone: a novel oral contraceptive
. Drugs Today
. 2022
;58
(1
):1
–8
. 22.
Douxfils
J
, Morimont
L
, Gaspard
U
, Utian
WH
, Foidart
J-M
. Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation
. Thromb Res
. 2023
;232
:148
–50
. 23.
Makabe
T
, Koga
K
, Miyashita
M
, Takeuchi
A
, Sue
F
, Taguchi
A
, et al. Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells
. J Reprod Immunol
. 2017
;119
:44
–8
. 24.
Grow
DR
, Iromloo
K
. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy
. Fertil Steril
. 2006
;85
(1
):204
–7
. 25.
Cicinelli
E
, Pinto
V
, Quattromini
P
, Fucci
MR
, Lepera
A
, Mitola
PC
, et al. Endometrial preparation with estradiol plus dienogest (Qlaira) for office hysteroscopic polypectomy: randomized pilot study
. J Minim Invasive Gynecol
. 2012
;19
(3
):356
–9
. 26.
Lauring
JR
, Lehman
EB
, Deimling
TA
, Legro
RS
, Chuang
CH
. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use
. Am J Obstet Gynecol
. 2016
;215
(3
):330.e1-7
. 27.
Centers for Disease Control and Prevention (CDC)
. US medical eligibility criteria for contraceptive use, 2010
. MMWR Recomm Rep
. 2010
;59
(RR-4
):1
–86
.28.
Vitale
SG
, Angioni
S
, D’Alterio
MN
, Ronsini
C
, Saponara
S
, De Franciscis
P
, et al. Risk of endometrial malignancy in women treated for breast cancer: the BLUSH prediction model - evidence from a comprehensive multicentric retrospective cohort study
. Climacteric
. 2024
;27
(5
):482
–8
. 29.
Kodama
M
, Onoue
M
, Otsuka
H
, Yada-Hashimoto
N
, Saeki
N
, Kodama
T
, et al. Efficacy of dienogest in thinning the endometrium before hysteroscopic surgery
. J Minim Invasive Gynecol
. 2013
;20
(6
):790
–5
. 30.
Török
P
, Molnár
S
, Herman
T
, Jashanjeet
S
, Lampé
R
, Riemma
G
, et al. Fallopian tubal obstruction is associated with increased pain experienced during office hysteroscopy: a retrospective study
. Updates Surg
. 2020
;72
(1
):213
–8
. 31.
Etrusco
A
, Laganà
AS
, Chiantera
V
, Gerli
S
, Carugno
J
, Sorrentino
F
, et al. Efficacy, safety, and feasibility of the treatment of intrauterine pathologies with the mini-resectoscope: a systematic review
. Int J Gynaecol Obstet
. 2024
;166
(2
):527
–37
. 32.
Etrusco
A
, Buzzaccarini
G
, Laganà
AS
, Chiantera
V
, Vitale
SG
, Angioni
S
, et al. Use of diode laser in hysteroscopy for the management of intrauterine pathology: a systematic review
. Diagnostics
. 2024
;14
(3
):327
. 33.
Vitale
SG
, Saponara
S
, Succu
AG
, Sicilia
G
, Martsidis
K
, D’Alterio
MN
, et al. Efficacy and safety of non-ablative dual wavelength diode laser therapy for genitourinary syndrome of menopause: a single-center prospective study
. Adv Ther
. 2024
;41
(12
):4617
–27
. 34.
Vitale
SG
, Moore
O
, Riemma
G
, Carugno
J
, Yarto
ML
, Haimovich
S
. Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study
. Climacteric
. 2023
;26
(5
):497
–502
. 35.
Ciscato
A
, Zare
SY
, Fadare
O
. The significance of recurrence in endometrial polyps: a clinicopathologic analysis
. Hum Pathol
. 2020
;100
:38
–44
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
